Blog

2 February 2025 - The Australian Government is listing Retevmo (selpercatinib) on the PBS for the first time to treat advanced ...

1 February 2025 - The February 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

31 January 2025 - Boehringer Ingelheim Korea said that Jardiance (empagliflozin) 10 mg tablet, its sodium-glucose co-transporter-2 inhibitor, received expanded ...

1 January 2025 - The January 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

2 January 2025 - Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines ...

 1 January 2025 - The January 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

6 December 2024 - More publicly funded medicines are on the way for people with types of breast and lung ...

1 December 2024 - The December 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

1 December 2024 - As of 1 December 2024, combination chemotherapy medicines, Opdualag and Vyxeos, will be transitioned from the Highly ...

1 December 2024 - The December 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

1 December 2024 - For the first time in three decades, women living with endometriosis will now have access to ...

20 November 2024 - Australians with osteoporosis, a type of skin lymphoma, spinal muscular atrophy and type 2 diabetes will ...

12 November 2024 - PHARMAC has decided to fund the medicine empagliflozin for thousands of people with a type of ...

8 November 2024 - PHARMAC has decided to fund lenvatinib from 1 December 2024 for people with some types of ...